NL300987I2 - - Google Patents

Info

Publication number
NL300987I2
NL300987I2 NL300987C NL300987C NL300987I2 NL 300987 I2 NL300987 I2 NL 300987I2 NL 300987 C NL300987 C NL 300987C NL 300987 C NL300987 C NL 300987C NL 300987 I2 NL300987 I2 NL 300987I2
Authority
NL
Netherlands
Application number
NL300987C
Other languages
Dutch (nl)
Other versions
NL300987I9 (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40795732&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300987(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NL300987I2 publication Critical patent/NL300987I2/nl
Publication of NL300987I9 publication Critical patent/NL300987I9/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL300987C 2007-12-19 2019-05-06 PACLITAXEL MICELLAiR NL300987I9 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/SE2007/001127 WO2009078754A1 (en) 2007-12-19 2007-12-19 Drug delivery system for administration of poorly water soluble pharmaceutically active substances
PCT/SE2008/051515 WO2009078802A1 (en) 2007-12-19 2008-12-18 Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Publications (2)

Publication Number Publication Date
NL300987I2 true NL300987I2 (OSRAM) 2019-05-09
NL300987I9 NL300987I9 (nl) 2019-05-16

Family

ID=40795732

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300987C NL300987I9 (nl) 2007-12-19 2019-05-06 PACLITAXEL MICELLAiR

Country Status (27)

Country Link
US (4) US8999382B2 (OSRAM)
EP (1) EP2231189B1 (OSRAM)
JP (1) JP5466172B2 (OSRAM)
KR (1) KR101572703B1 (OSRAM)
CN (1) CN101951956B (OSRAM)
AU (1) AU2008339099B2 (OSRAM)
BR (1) BRPI0821740B1 (OSRAM)
CA (1) CA2709266C (OSRAM)
CY (2) CY1119805T1 (OSRAM)
DK (1) DK2231189T3 (OSRAM)
EA (1) EA015247B1 (OSRAM)
ES (1) ES2650242T3 (OSRAM)
FR (1) FR19C1030I1 (OSRAM)
HR (1) HRP20171796T1 (OSRAM)
HU (1) HUE034684T2 (OSRAM)
LT (2) LT2231189T (OSRAM)
LU (1) LUC00117I2 (OSRAM)
MX (1) MX2010006914A (OSRAM)
MY (2) MY157186A (OSRAM)
NL (1) NL300987I9 (OSRAM)
NO (2) NO2231189T3 (OSRAM)
NZ (1) NZ586859A (OSRAM)
PL (1) PL2231189T3 (OSRAM)
PT (1) PT2231189T (OSRAM)
SI (1) SI2231189T1 (OSRAM)
WO (2) WO2009078754A1 (OSRAM)
ZA (1) ZA201004685B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009078756A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances
KR20120022984A (ko) * 2009-04-21 2012-03-12 셀렉타 바이오사이언시즈, 인크. Ｔｈ１ 편향 반응을 제공하는 면역나노치료법
NO2575876T3 (OSRAM) 2010-05-26 2018-05-05
EP2640190A4 (en) 2010-11-05 2016-05-11 Selecta Biosciences Inc MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
CN103908432B (zh) * 2013-01-02 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种伊沙匹隆白蛋白的冻干组合物及其制备方法
CN112321465B (zh) * 2019-07-18 2023-06-06 上海现代药物制剂工程研究中心有限公司 一种含苯基化合物、其中间体、制备方法及应用
CN112239418B (zh) * 2019-07-18 2023-07-07 上海现代药物制剂工程研究中心有限公司 视黄醇类化合物及其钠盐的制备方法
WO2021259472A1 (en) * 2020-06-24 2021-12-30 Oasmia Pharmaceutical Ab Micellar docetaxel for use in the treatment of cancer
CN115429886B (zh) * 2021-06-02 2025-10-31 复旦大学 一种药物纳米结晶制剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096331A (en) * 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
DE19839566C2 (de) * 1998-08-31 2002-01-17 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten in der Transplantationsmedizin
US6197809B1 (en) * 1998-12-23 2001-03-06 Ardenia Investments Ltd. Compounds for the treatment of cancer
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
SE0101702D0 (sv) * 2001-05-15 2001-05-15 Ardenia Investments Ltd Novel potentiating compounds
US20050191359A1 (en) * 2001-09-28 2005-09-01 Solubest Ltd. Water soluble nanoparticles and method for their production
US20050249786A1 (en) * 2001-09-28 2005-11-10 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
HK1080447B (zh) * 2002-07-23 2008-10-31 Ardenia Investments, Ltd. 视黄醇衍生物、它们在治疗癌症和增强其它细胞毒性剂功效中的应用
SE0202311D0 (sv) * 2002-07-23 2002-07-23 Ardenia Investments Ltd Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
US7259984B2 (en) * 2002-11-26 2007-08-21 Cornell Research Foundation, Inc. Multibit metal nanocrystal memories and fabrication
JP2006199590A (ja) 2003-09-04 2006-08-03 Nano Career Kk 水溶性の塩基性薬物内包ナノ粒子含有組成物
WO2005089106A2 (en) 2004-02-27 2005-09-29 Molecular Therapeutics, Inc. Degradable nanoparticles
US7871632B2 (en) 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8945629B2 (en) * 2004-09-10 2015-02-03 University Of Wyoming Nanoparticles for cytoplasmic drug delivery to cancer cells
CN101291658B (zh) * 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078754A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of poorly water soluble pharmaceutically active substances

Also Published As

Publication number Publication date
US8999382B2 (en) 2015-04-07
EP2231189A4 (en) 2013-10-09
US9993438B2 (en) 2018-06-12
WO2009078802A1 (en) 2009-06-25
BRPI0821740B1 (pt) 2021-05-18
AU2008339099A1 (en) 2009-06-25
EP2231189A1 (en) 2010-09-29
JP2011507838A (ja) 2011-03-10
NL300987I9 (nl) 2019-05-16
PL2231189T3 (pl) 2018-03-30
US20150164819A1 (en) 2015-06-18
USRE49742E1 (en) 2023-12-05
CN101951956B (zh) 2012-10-17
PT2231189T (pt) 2017-12-12
NZ586859A (en) 2012-06-29
CY1119805T1 (el) 2018-06-27
DK2231189T3 (en) 2017-12-11
NO2231189T3 (OSRAM) 2018-02-03
LT2231189T (lt) 2017-12-27
CY2019021I2 (el) 2019-11-27
CA2709266A1 (en) 2009-06-25
MY157187A (en) 2016-05-13
US20110014281A1 (en) 2011-01-20
USRE49741E1 (en) 2023-12-05
CN101951956A (zh) 2011-01-19
CY2019021I1 (el) 2019-11-27
NO2019023I1 (no) 2019-05-08
MX2010006914A (es) 2010-11-10
CA2709266C (en) 2017-09-26
KR20100094575A (ko) 2010-08-26
EP2231189B1 (en) 2017-09-06
ZA201004685B (en) 2011-03-30
FR19C1030I1 (fr) 2019-06-21
ES2650242T3 (es) 2018-01-17
EA015247B1 (ru) 2011-06-30
HUE034684T2 (en) 2018-02-28
HRP20171796T1 (hr) 2018-01-26
BRPI0821740A2 (pt) 2020-02-27
SI2231189T1 (en) 2018-03-30
WO2009078754A1 (en) 2009-06-25
MY157186A (en) 2016-05-13
KR101572703B1 (ko) 2015-11-27
AU2008339099B2 (en) 2015-08-13
LUC00117I2 (OSRAM) 2024-05-22
JP5466172B2 (ja) 2014-04-09
EA200802350A2 (ru) 2009-06-30
EA200802350A3 (ru) 2009-10-30
LTPA2019508I1 (lt) 2019-05-10

Similar Documents

Publication Publication Date Title
BRPI0819772A2 (OSRAM)
BRPI0818933A2 (OSRAM)
CN300727585S (zh) 收音机(带手摇电筒的收音机)
CN300728134S (zh) 蚊蝇诱饵盒(方形)
CN300728437S (zh) 射灯(led-f)
CN300728364S (zh) 手电筒(ksl-0526)
CN300728352S (zh) 连椅花架(2)
CN300728322S (zh) 型材（隐形纱窗卷纱箱）
CN300728308S (zh) 型材(pm5832)
CN300727788S (zh) 自动送拧螺丝机
CN300727813S (zh) 电吉它(5)
CN300726578S (zh) 枕套(和谐)
CN300726326S (zh) 椅子(2105)
CN300728063S (zh) 弹跳鞋(成人)
CN300726307S (zh) 沙发(8038)
CN300727708S (zh) 滚筒疏松器
CN300727592S (zh) 电子笔
CN300727196S (zh) 纸篓(1)
CN300727586S (zh) 迷你音箱(cql1065)
CN300727958S (zh) 标牌(预防接种麻疹疫苗)
CN300726250S (zh) 壁纸(4)
CN300726260S (zh) 墙纸(17a)
CN300726262S (zh) 墙纸(12a)
CN300726286S (zh) 装饰玻璃(粉红竖八条10-10)
CN300727579S (zh) 音响(sy-606)